Inmaculada Conejos‐Sánchez

1.3k total citations · 1 hit paper
20 papers, 939 citations indexed

About

Inmaculada Conejos‐Sánchez is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Inmaculada Conejos‐Sánchez has authored 20 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Inmaculada Conejos‐Sánchez's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Inmaculada Conejos‐Sánchez is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Inmaculada Conejos‐Sánchez collaborates with scholars based in Spain, Portugal and Germany. Inmaculada Conejos‐Sánchez's co-authors include Marı́a J. Vicent, Aroa Duro‐Castaño, Snežana Đorđević, Marı́a José Alonso, Brendan T. Griffin, Caitríona M. O’Driscoll, Zhigao Niu, María Medel, Rita C. Acúrcio and Bárbara Carreira and has published in prestigious journals such as Advanced Materials, Chemistry of Materials and Advanced Drug Delivery Reviews.

In The Last Decade

Inmaculada Conejos‐Sánchez

18 papers receiving 934 citations

Hit Papers

Current hurdles to the translation of nanomedicines from ... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

Inmaculada Conejos‐Sánchez
Inmaculada Conejos‐Sánchez
Citations per year, relative to Inmaculada Conejos‐Sánchez Inmaculada Conejos‐Sánchez (= 1×) peers Nolwenn Lautram

Countries citing papers authored by Inmaculada Conejos‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Conejos‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Conejos‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Conejos‐Sánchez more than expected).

Fields of papers citing papers by Inmaculada Conejos‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Conejos‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Conejos‐Sánchez. The network helps show where Inmaculada Conejos‐Sánchez may publish in the future.

Co-authorship network of co-authors of Inmaculada Conejos‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Conejos‐Sánchez. A scholar is included among the top collaborators of Inmaculada Conejos‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Conejos‐Sánchez. Inmaculada Conejos‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moura, Liane I.F., Alessio Malfanti, Ana I. Matos, et al.. (2025). Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma. Advanced Materials. 37(16). e2417348–e2417348. 5 indexed citations
2.
Masiá, Esther, et al.. (2025). A light-driven molecular motor-polypeptide conjugate supports controlled cell uptake. Journal of Materials Chemistry B. 13(8). 2658–2665.
3.
Masiá, Esther, Cristián Huck‐Iriart, Pavel Arsenyan, et al.. (2025). Polyproline‐Polyornithine Diblock Copolymers with Inherent Mitochondria Tropism. Advanced Materials. 37(8). e2411595–e2411595. 6 indexed citations
4.
Masiá, Esther, et al.. (2025). Multifunctional Polypeptide-Based Nanoconjugates for Targeted Mitochondrial Delivery and Nonviral Gene Therapy. Chemistry of Materials. 37(4). 1457–1467. 4 indexed citations
5.
Atkinson, Stuart P., et al.. (2025). Polymer-based nanomedicines: Supporting multimodal approaches to glioblastoma multiforme treatment. Advanced Drug Delivery Reviews. 228. 115735–115735.
6.
Conejos‐Sánchez, Inmaculada, et al.. (2024). Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques. Advanced Drug Delivery Reviews. 207. 115195–115195. 18 indexed citations
7.
Đorđević, Snežana, et al.. (2023). Critical Design Strategies Supporting Optimized Drug Release from Polymer–Drug Conjugates. Small. 20(4). e2303157–e2303157. 8 indexed citations
8.
Masiá, Esther, et al.. (2023). Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment. Journal of Controlled Release. 355. 385–394. 8 indexed citations
9.
Duro‐Castaño, Aroa, Consuelo Borrás, Vicente Herranz‐Pérez, et al.. (2021). Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates. Science Advances. 7(13). 45 indexed citations
10.
Bouzo, Belén L., et al.. (2021). Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer. Scientific Reports. 11(1). 17213–17213. 24 indexed citations
11.
Đorđević, Snežana, María Medel, Inmaculada Conejos‐Sánchez, et al.. (2021). Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Delivery and Translational Research. 12(3). 500–525. 284 indexed citations breakdown →
12.
Đorđević, Snežana, et al.. (2020). Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation. Advanced Drug Delivery Reviews. 160. 136–169. 55 indexed citations
13.
Conejos‐Sánchez, Inmaculada, Jayden A. Smith, Alerie Guzman de la Fuente, et al.. (2019). Polyornithine-based polyplexes to boost effective gene silencing in CNS disorders. Nanoscale. 12(11). 6285–6299. 16 indexed citations
14.
Duro‐Castaño, Aroa, et al.. (2018). Envisioning the future of polymer therapeutics for brain disorders. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 11(1). e1532–e1532. 25 indexed citations
15.
Niu, Zhigao, Inmaculada Conejos‐Sánchez, Brendan T. Griffin, Caitríona M. O’Driscoll, & Marı́a José Alonso. (2016). Lipid-based nanocarriers for oral peptide delivery. Advanced Drug Delivery Reviews. 106(Pt B). 337–354. 215 indexed citations
16.
Conejos‐Sánchez, Inmaculada, Isabel Cardoso, Marta Oteo, et al.. (2014). Polymer-doxycycline conjugates as fibril disrupters: An approach towards the treatment of a rare amyloidotic disease. Journal of Controlled Release. 198. 80–90. 24 indexed citations
17.
Duro‐Castaño, Aroa, Inmaculada Conejos‐Sánchez, & Marı́a J. Vicent. (2014). Peptide-Based Polymer Therapeutics. Polymers. 6(2). 515–551. 78 indexed citations
18.
Conejos‐Sánchez, Inmaculada, Isabel Cardoso, Maria João Saraiva, & Marı́a J. Vicent. (2014). Targeting a rare amyloidotic disease through rationally designed polymer conjugates. Journal of Controlled Release. 178. 95–100. 9 indexed citations
19.
Conejos‐Sánchez, Inmaculada, Aroa Duro‐Castaño, Alexander Birke, Matthias Barz, & Marı́a J. Vicent. (2013). A controlled and versatile NCA polymerization method for the synthesis of polypeptides. Polymer Chemistry. 4(11). 3182–3182. 110 indexed citations
20.
Conejos‐Sánchez, Inmaculada, G. Hampel, Stefan Zauner, & Josef Riederer. (2009). Reverse paintings on glass—A new approach for dating and localization. Applied Radiation and Isotopes. 67(12). 2113–2116. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026